Recent developments in the pathogenesis, diagnosis and treatment of celiac disease

Bibliography

• FASANO A, CATASSI C: Approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology (2001) 120:636–651.
   PubMed Web of Science ®Google Scholar
• SCHUPPAN D Current concepts of celiac disease pathogenesis. Gastroenterology (2000) 119:234–242.
   PubMed Web of Science ®Google Scholar
• •This paper represents a comprehensive review on the current concepts of CD pathophysiology.
   Google Scholar
• SOLLID LM, THORSBY E: HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 105:910–922.
   PubMed Web of Science ®Google Scholar
• SOLLID LM, MAKUSSEN G, EK Jet al.: Evidence for a primary association of celiac disease to a particular HLA-DQ (1/3 heterodimer. J. Exp. Med. (1989) 169: 345–350
   Google Scholar
• BJORKMAN PJ, SAPER MA, SAMRAOUI B et al.: The foreign antigen binding site and T-cell recognition regions of class I immunohistocompatibility antigens. Nature (1987) 329:512
   PubMed Web of Science ®Google Scholar
• CUVELIER C, BARBATIS C, MIELANTS H et al.: Histopathology of intestinal inflammation related to reactive arthritis. Gut (1987) 28:394–401.
   PubMed Web of Science ®Google Scholar
• DIETERICH W, EHNIS T, BAUER M et al.: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. (1997) 3:797–801.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the identification oftissue transglutaminase as the principle antigen recognised by anti-endomysium antibodies.
   Google Scholar
• MOLBERG O, McADAM SN, SOLLIDLM. Role ot tissue transglutaminase in celiac disease. J. Pediatr. GastroenteroL Nutr. (2000) 30:232–240
   PubMedGoogle Scholar
• CATASSI C, RATSCH IM, FABIANI E et al.: Coeliac disease in the year 2000: exploring the iceberg. Lancet (1994) 343:200–203.
   PubMed Web of Science ®Google Scholar
• DI PIETRALATA M, GIORGETTI GM, GREGORI Met al.: Sub-clinical coeliac disease. Ital. J .Gastroenterol .( 1992) 24:352–354.
   PubMedGoogle Scholar
• GRODZINSKY E, FRANZEN L, HED Jet al.: High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann All. (1992) 69:66–70.
   Google Scholar
• ASCHER H, KRANTZ I, KRISTIANSSON B: Increasing incidence of coeliac disease in Sweden. Arch. Dis. Child (1991) 66:608–611.
   PubMed Web of Science ®Google Scholar
• KOLHO KL, FARKKILA MA, SAVILAHTI E: Undiagnosed coeliac disease is common in Finnish adults. Scand. J. GastroenteroL (1998) 33:1280–1283.
   PubMed Web of Science ®Google Scholar
• CATASSI C, FABIANI E, RATSCH IM et al.: The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta. Paediatr. SuppL (1996) 412:29–35.
   Google Scholar
• HILL ID, HORVATH K, FASANO A: Epidemiology of Celiac Disease. Am. J. GastroenteroL (1995) 90:163–164.
   PubMed Web of Science ®Google Scholar
• BERTI I, HORVATH K, GREEN PHR et al.: Prevalence of celiac disease among risk groups and the general population in USA. J. Invest. Med. (2000) 48:206:220A.
   Google Scholar
• NOT T, HORVATH K, HILL ID et aL: Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J. GastroenteroL (1998) 33:494–498.
   PubMed Web of Science ®Google Scholar
• GANDOLFI L, PRATESI R, CORDOBA JCM et al.: Prevalence of celiac disease among blood donors in Brazil. Am. J. GastroenteroL (2000) 95:689–692.
   PubMed Web of Science ®Google Scholar
• CATASSI C, RATSCH IM, GANDOLFI L et aL Why is coeliac disease endemic in the people of the Sahara. Lancet (1999) 354:647–648.
   PubMed Web of Science ®Google Scholar
• CARROCCIO A, IANNYFEO E, CAVATAIO F et aL: Sideropenic anemia and celiac disease: one study, two points of view. Dig. Dis. Sci. (1998) 43:673–678.
   PubMed Web of Science ®Google Scholar
• GROLL, CANDY DCA, PEECE MA et al.:Short stature as the primary manifestation of coeliac disease. Lancet (1980) 22:1097–1099.
   Google Scholar
• PELLECCHIA MT, SCALA R, FILLA A et al.: Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J. NeuroL Neurosurg Psychiatry (1999) 66:32–35.
   PubMed Web of Science ®Google Scholar
• BOTTARO G, CATALDO F, ROTOLO N et aL The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J. GastroenteroL (1999) 94: 691–696.
   PubMed Web of Science ®Google Scholar
• FERGUSON A, ARRANZ E, O'MAHONY S: Clinical and pathological spectrum of coeliac disease- active, silent, latent, potential. Gut (1993) 34:150–151.
   PubMed Web of Science ®Google Scholar
• SBLATTERO D, BERTI I, TREVISOL C et aL: Human recombinant tissue transglutaminase ELISA: a powerful mass screening diagnostic assay for symptomatic and asymptomatic coeliac disease. Am. J. GastroenteroL (2000) 95:1253–1257.
   PubMed Web of Science ®Google Scholar
• MADARA JL, TRIER JS: Structural abnormalities of jejunal epithelial cell membranes in celiac sprue. Lab. Awes. (1980) 43:254–261.
   Google Scholar
• SCHULZKE JD, BENTZEL CJ, SCHULZKE I et aL Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Ped. Res. (1998) 43:435–441.
   PubMedGoogle Scholar
• •This paper identified the intercellular tight junctions as affected structures involved in the increased intestinal permeability typical of the acute phase of CD.
   Google Scholar
• WANG W, UZZAU S, GOLDBLUM SE et al.: Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. (2000) 113:4435–4440.
   PubMed Web of Science ®Google Scholar
• FASANO A, NOT T, WANG Wet aL: Zonulin, a newly discovered modulator of
   Google Scholar
• Expert Opin. Ther Patents (2002) 12(1) intestinal permeability, and its expression in coeliac disease. Lancet (2000) 358:1518–1519.
   Google Scholar
• •This paper describes the discovery of zonulin, a molecule that modulates intercellular tight junctions, whose up-regulation seems to be involved in CD pathogenesis.
   Google Scholar
• VENTURA A, MAGAZZU G, GRECO L: Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology (1999) 117:303–310.
   Google Scholar
• •This report provides indirect evidence of the relationship between the length of gluten exposure and the risk of autoimmune diseases in CD patients.
   Google Scholar
• CORNELL H, WIESER H, BELITZ HD. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease. Clin. Chim. Acta. (1992) 213:37–50.
   Google Scholar
• WIESER H. The precipitating factor in coeliac disease. Bailliere's Clin .Gastroenterol (1995) 9:191–207.
   PubMed Web of Science ®Google Scholar
• DE VINCENZI M, LUCHETTI R, PERUFFO AD et al.: In vitro assessment of acetic acid-soluble proteins (glutenin) in celiac disease. J. Biochem. Toxicol (1996) 11:205–210.
   PubMedGoogle Scholar
• JOHANNSEN BH, VARTDAL F, ERIKSEN JA et al.: Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunolog. (1996) 8:177–182.
   PubMedGoogle Scholar
• SOLLID LM: Autoantibodies in coelic disease: tissue tranglutaminase-guilt by association? Gut (1997) 47:851–852.
   Google Scholar
• PENDER SL, TICKEL SP, DOCHERTY AJ et al.: A major role of matrix metalloproteinases in T cell injury in the gut. J. immune/. (1997) 158:1582–1590.
   PubMed Web of Science ®Google Scholar
• CARROCCIO A, FABIANI E, IANNITTO E et al.: Tissue transglutaminase autoantibodies in patients with non-Hodgkin lymphoma. Case reports. Digestion (2000) 62:271–275.
   Google Scholar
• MARTINIS, MENGOZZI G, AIMO Get al.: Diagnostic accuracies for celiac disease of four tissue transglutaminase autoantibody tests using human antigen. Clin. Chem. (2001) 47:1722–1725.
   Google Scholar
• CORRAO G, CORAZZA GR, BAGNARDI Vet al.: Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 358:356–361.
   Google Scholar
• ANDERSON RP, DEGANO P, GODKIN AJ et al.: In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat .Med. (2000) 3:337–342.
   Google Scholar
• MAIURI L, CIACCI C, AURICCHIO S,BROWN V, QUARATINO S, LONDEI M: Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology (2000) 119:996–1006.
   PubMed Web of Science ®Google Scholar